CHK1 as a therapeutic target to bypass chemoresistance in AML
暂无分享，去创建一个
S. Manenti | C. Récher | E. Delabesse | C. Cazaux | J. Hoffmann | J. Sarry | C. Larrue | S. Bertoli | B. Lepage | N. Prade | C. Didier | A. Fernandez-Vidal | S. Grgurevic | L. David | M. Cartel | D. Deshaies | É. Delabesse | Christine Didier